Literature DB >> 28751268

The stem cell factor (SCF)/c-KIT system in carcinogenesis of reproductive tissues: What does the hormonal regulation tell us?

Marília I Figueira1, Henrique J Cardoso1, Sara Correia1, Cláudio J Maia2, Sílvia Socorro3.   

Abstract

The tyrosine kinase receptor c-KIT and its ligand, the stem cell factor (SCF) are expressed in several tissues of male and female reproductive tract, playing an important role in the regulation of basic biological processes. The activation of c-KIT by SCF controls, cell survival and death, cell differentiation and migration. Also, the SCF/c-KIT system has been implicated in carcinogenesis of reproductive tissues due to its altered expression pattern or overactivation in consequence of gain-of-functions mutations. Over the years, it has also been shown that hormones, the primary regulators of reproductive function and causative agents in the case of hormone-dependent cancers, are also able to control the SCF/c-KIT tissue levels. Therefore, it is liable to suppose that disturbed SCF/c-KIT expression driven by (de)regulated hormone actions can be a relevant step towards carcinogenesis. The present review describes the SCF and c-KIT expression in cancers of reproductive tissues, discussing the implications of the hormonal regulation of the SCF/c-KIT system in cancer development. Understanding the relationship between hormonal imbalance and the SCF/c-KIT expression and activity would be relevant in the context of novel therapeutic approaches in reproductive cancers.
Copyright © 2017 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Carcinogenesis; Hormone-dependent cancers; Reproductive tissues; SCF; c-KIT

Mesh:

Substances:

Year:  2017        PMID: 28751268     DOI: 10.1016/j.canlet.2017.07.017

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  3 in total

1.  Tissue distribution of stem cell factor in adults.

Authors:  Brittni M Foster; Kendall L Langsten; Ammar Mansour; Lihong Shi; Bethany A Kerr
Journal:  Exp Mol Pathol       Date:  2021-08-24       Impact factor: 4.401

2.  BMP signaling is a therapeutic target in ovarian cancer.

Authors:  Tomohiko Fukuda; Risa Fukuda; Ryo Tanabe; Daizo Koinuma; Hiroo Koyama; Yoshinobu Hashizume; Aristidis Moustakas; Kohei Miyazono; Carl-Henrik Heldin
Journal:  Cell Death Discov       Date:  2020-12-05

Review 3.  Tissue-Specific Molecular Markers and Heterogeneity in Type 2 Innate Lymphoid Cells.

Authors:  Enrique Olguín-Martínez; Blanca E Ruiz-Medina; Paula Licona-Limón
Journal:  Front Immunol       Date:  2021-10-25       Impact factor: 7.561

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.